Birks Group Stock Forecast, Price & News

+0.39 (+26.35 %)
(As of 05/11/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume4.28 million shs
Average Volume1.32 million shs
Market Capitalization$33.61 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive BGI News and Ratings via Email

Sign-up to receive the latest news and ratings for Birks Group and its competitors with MarketBeat's FREE daily newsletter.

Birks Group logo

About Birks Group

Birks Group Inc. designs, develops, manufactures, and retails fine jewelry, timepieces, sterling and plated silverware, and gifts in the United States and Canada. The company operates through two segments, Retail and Other. It offers various merchandise, including designer jewelry, diamonds, gemstone and precious metal jewelry, rings, wedding bands, earrings, bracelets, necklaces, charms, and pearls. As of May 31, 2020, the company operated 27 Birks stores under the Maison Birks brand in various metropolitan markets in Canada; 1 retail location under the Brinkhaus brand in Calgary; and 2 retail locations under the Graff and Patek Philippe brands in Vancouver. It also engages in the retail and wholesale of fine jewelry collections through Mappin & Webb and Goldsmiths stores, as well as through e-commerce platforms; and gold exchange business. The company was formerly known as Birks & Mayors Inc. and changed its name to Birks Group Inc. in October 2013. Birks Group Inc. was founded in 1879 and is headquartered in Montreal, Canada.


See More Headlines

Industry, Sector and Symbol

Industry Jewelry stores
Year FoundedN/A

Sales & Book Value

Annual Sales$126.32 million
Book Value$0.25 per share





Market Cap$33.61 million
Next Earnings Date7/14/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

0.85 out of 5 stars

Retail/Wholesale Sector

227th out of 382 stocks

Jewelry Stores Industry

4th out of 7 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Birks Group (NYSEAMERICAN:BGI) Frequently Asked Questions

What stocks does MarketBeat like better than Birks Group?

Wall Street analysts have given Birks Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Birks Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Birks Group?

Birks Group saw a increase in short interest in April. As of April 15th, there was short interest totaling 108,700 shares, an increase of 21.3% from the March 31st total of 89,600 shares. Based on an average daily volume of 1,150,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 2.9% of the shares of the stock are sold short.
View Birks Group's Short Interest

When is Birks Group's next earnings date?

Birks Group is scheduled to release its next quarterly earnings announcement on Wednesday, July 14th 2021.
View our earnings forecast for Birks Group

Who are Birks Group's key executives?

Birks Group's management team includes the following people:
  • Mr. Jean-Christophe Bédos, Pres, CEO & Director (Age 56, Pay $946.75k)
  • Mr. Marco Pasteris, VP of Bus. Devel. & Support (Age 60, Pay $320.46k)
  • Mr. Niccolò Rossi di Montelera, Exec. Chairman (Age 48)
  • Ms. Katia Fontana, VP & CFO (Age 51)
  • Ms. Miranda Melfi, VP of HR, Chief Legal Officer & Corp. Sec. (Age 57)
  • Ms. Eva Hartling, Chief Marketing Officer & VP of Birks Brand (Age 40)

Who are some of Birks Group's key competitors?

What other stocks do shareholders of Birks Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Birks Group investors own include Evoke Pharma (EVOK), Immutep (IMMP), Ampio Pharmaceuticals (AMPE), Boxlight (BOXL), electroCore (ECOR), Gevo (GEVO), Great Panther Mining (GPL), Achieve Life Sciences (ACHV), Adamis Pharmaceuticals (ADMP) and Alpine Immune Sciences (ALPN).

What is Birks Group's stock symbol?

Birks Group trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BGI."

How do I buy shares of Birks Group?

Shares of BGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Birks Group's stock price today?

One share of BGI stock can currently be purchased for approximately $1.87.

How much money does Birks Group make?

Birks Group has a market capitalization of $33.61 million and generates $126.32 million in revenue each year.

How many employees does Birks Group have?

Birks Group employs 365 workers across the globe.

What is Birks Group's official website?

The official website for Birks Group is www.birksgroup.com.

Where are Birks Group's headquarters?

Birks Group is headquartered at 1240 Square Phillips, MONTREAL, QC H3B 3H4, Canada.

How can I contact Birks Group?

Birks Group's mailing address is 1240 Square Phillips, MONTREAL, QC H3B 3H4, Canada. The company can be reached via phone at +1-514-3972592 or via email at [email protected]

This page was last updated on 5/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.